Vanda Pharmaceuticals (VNDA) Inventory Average (2012 - 2026)

Vanda Pharmaceuticals has disclosed Inventory Average across 15 years of filings, most recently posting $10.8 million for Q1 2026.

• Inventory Average for Q1 2026 came in at $10.8 million, up 8.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.8 million (up 8.75% YoY), and the FY2025 annual result was $10.3 million, up 88.9% from the prior year.
• Inventory Average came in at $10.8 million for Q1 2026 at Vanda Pharmaceuticals, up from $10.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $11.3 million in Q4 2022 to a low of $1.2 million in Q1 2022.
• The 5-year median for Inventory Average is $6.3 million (2022), against an average of $7.0 million.
• Across the five-year window, Inventory Average sank 84.91% in 2024 and soared 561.6% in 2025, its largest moves.
• Vanda Pharmaceuticals' Inventory Average stood at $11.3 million in 2022, then slumped by 48.55% to $5.8 million in 2023, then fell by 4.08% to $5.6 million in 2024, then soared by 89.26% to $10.5 million in 2025, then increased by 2.23% to $10.8 million in 2026.
• The last three Inventory Average figures came in at $10.8 million (Q1 2026), $10.5 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.